Biotechnology
The Biotechnology industry has a total of 595 stocks, with a combined market cap of $1.33 trillion and total revenue of $115.7 billion.
Market Cap
1.33T
Revenue
115.7B
Profits
-39.65B
PE Ratio
n/a
Profit Margin
-34.27%
Dividend Yield
0.04%
595 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 134.13B | 2.65% | 363,601 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 81.71B | 1.54% | 161,034 | 15.53B |
| 3 | ARGX | argenx SE | 61.95B | 1.93% | 105,573 | 5.32B |
| 4 | RVMD | Revolution Medicines, Inc. | 45.51B | 0.16% | 601,500 | - |
| 5 | ONC | BeOne Medicines AG | 41.90B | 1.65% | 155,537 | 6.13B |
| 6 | RPRX | Royalty Pharma plc | 34.57B | 1.13% | 639,032 | 2.54B |
| 7 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.56B | 1.68% | 419,059 | 4.80B |
| 8 | INSM | Insmed Incorporated | 27.94B | -0.30% | 296,932 | 1.14B |
| 9 | ROIV | Roivant Sciences Ltd. | 26.28B | 0.40% | 868,423 | 7.53M |
| 10 | INCY | Incyte Corporation | 25.18B | 0.57% | 206,898 | 5.82B |
| 11 | MRNA | Moderna, Inc. | 25.13B | -2.34% | 1,322,093 | 2.23B |
| 12 | BNTX | BioNTech SE | 23.12B | 0.48% | 157,347 | 3.03B |
| 13 | GMAB | Genmab A/S | 19.46B | -0.27% | 1,017,882 | 4.13B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 16.52B | 2.48% | 146,443 | 4.60B |
| 15 | ASND | Ascendis Pharma A/S | 16.45B | 1.26% | 109,491 | 1.20B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 16.37B | 4.79% | 889,733 | 713.07M |
| 17 | BMRN | BioMarin Pharmaceutical Inc. | 13.18B | 2.21% | 339,369 | 3.41B |
| 18 | EXEL | Exelixis, Inc. | 13.18B | 1.66% | 306,950 | 2.44B |
| 19 | CORT | Corcept Therapeutics Incorporated | 12.82B | 1.19% | 206,802 | 830.81M |
| 20 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.26B | -2.14% | 321,996 | 669.50M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.25B | 1.06% | 62,627 | 1.28B |
| 22 | HALO | Halozyme Therapeutics, Inc. | 11.81B | 1.05% | 469,047 | 1.66B |
| 23 | AXSM | Axsome Therapeutics, Inc. | 11.39B | 0.57% | 104,581 | 776.57M |
| 24 | TECH | Bio-Techne Corporation | 11.27B | -0.07% | 1,608,348 | 1.22B |
| 25 | ABVX | ABIVAX Société Anonyme | 10.57B | -1.42% | 182,325 | 5.67M |
| 26 | CYTK | Cytokinetics, Incorporated | 10.49B | -0.51% | 635,771 | 67.67M |
| 27 | PRAX | Praxis Precision Medicines, Inc. | 10.32B | -1.84% | 131,317 | 7.46M |
| 28 | PTGX | Protagonist Therapeutics, Inc. | 10.24B | -0.21% | 89,263 | 281.99M |
| 29 | SMMT | Summit Therapeutics Inc. | 10.19B | -0.08% | 1,531,843 | - |
| 30 | APGE | Apogee Therapeutics, Inc. | 10.15B | -0.01% | 349,461 | - |
| 31 | IONS | Ionis Pharmaceuticals, Inc. | 9.94B | 1.98% | 620,353 | 874.09M |
| 32 | KRYS | Krystal Biotech, Inc. | 9.90B | -0.33% | 38,308 | 440.48M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 9.90B | -1.89% | 165,705 | 105.00M |
| 34 | SYRE | Spyre Therapeutics, Inc. | 9.45B | 2.47% | 320,544 | - |
| 35 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.99B | 0.04% | 1,164,071 | 42.16M |
| 36 | PCVX | Vaxcyte, Inc. | 8.95B | -0.12% | 139,139 | - |
| 37 | IMVT | Immunovant, Inc. | 8.94B | -0.96% | 271,764 | - |
| 38 | IBRX | ImmunityBio, Inc. | 8.09B | -3.60% | 2,224,545 | 165.79M |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 8.01B | 0.79% | 151,408 | 239.92M |
| 40 | ORKA | Oruka Therapeutics, Inc. | 7.31B | -1.97% | 203,042 | - |
| 41 | TGTX | TG Therapeutics, Inc. | 7.04B | 0.76% | 187,007 | 799.54M |
| 42 | CGON | CG Oncology, Inc. | 6.73B | -1.56% | 137,846 | 6.23M |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 6.54B | 0.89% | 114,216 | 618.07M |
| 44 | SRRK | Scholar Rock Holding Corporation | 6.50B | 2.58% | 293,858 | - |
| 45 | COGT | Cogent Biosciences, Inc. | 6.46B | -1.76% | 306,789 | - |
| 46 | DNTH | Dianthus Therapeutics, Inc. | 6.41B | -0.30% | 155,719 | 1.90M |
| 47 | ERAS | Erasca, Inc. | 6.33B | -1.04% | 609,011 | - |
| 48 | BLTE | Belite Bio, Inc | 6.32B | -1.58% | 21,693 | - |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 6.10B | 1.07% | 366,650 | 7.50M |
| 50 | PTCT | PTC Therapeutics, Inc. | 6.07B | -0.18% | 199,180 | 1.01B |
| 51 | DFTX | Definium Therapeutics, Inc. | 5.96B | -1.97% | 679,621 | - |
| 52 | TVTX | Travere Therapeutics, Inc. | 5.96B | -0.50% | 297,881 | 591.33M |
| 53 | CAI | Caris Life Sciences, Inc. | 5.95B | -2.73% | 1,064,840 | 989.61M |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 5.72B | -1.58% | 48,194 | 290.54M |
| 55 | ACAD | ACADIA Pharmaceuticals Inc. | 5.10B | 2.07% | 513,842 | 1.14B |
| 56 | CRSP | CRISPR Therapeutics AG | 5.05B | -3.78% | 515,409 | 13.39M |
| 57 | DYN | Dyne Therapeutics, Inc. | 4.79B | -1.95% | 278,084 | - |
| 58 | PBLS | Parabilis Medicines, Inc. | 4.79B | 4.14% | 192,568 | 148.00K |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 4.79B | 0.08% | 339,890 | - |
| 60 | CELC | Celcuity Inc. | 4.53B | 0.04% | 192,585 | - |
| 61 | MANE | Veradermics, Incorporated | 4.51B | -0.28% | 103,097 | - |
| 62 | RLAY | Relay Therapeutics, Inc. | 4.48B | -1.02% | 498,172 | 10.35M |
| 63 | ELVN | Enliven Therapeutics, Inc. | 4.39B | 0.75% | 236,462 | - |
| 64 | TNGX | Tango Therapeutics, Inc. | 4.25B | -0.36% | 599,546 | 53.81M |
| 65 | TLX | Telix Pharmaceuticals Limited | 4.05B | 1.24% | 12,174 | 803.79M |
| 66 | LEGN | Legend Biotech Corporation | 3.97B | -0.53% | 325,192 | 1.27B |
| 67 | VKTX | Viking Therapeutics, Inc. | 3.88B | -1.16% | 319,718 | - |
| 68 | DNLI | Denali Therapeutics Inc. | 3.86B | -0.86% | 295,324 | 3.60M |
| 69 | GPCR | Structure Therapeutics Inc. | 3.78B | -1.40% | 157,151 | - |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.72B | -1.08% | 336,661 | 117.00M |
| 71 | ABCL | AbCellera Biologics Inc. | 3.57B | -1.52% | 3,757,593 | 66.17M |
| 72 | IDYA | IDEAYA Biosciences, Inc. | 3.55B | 0.57% | 66,355 | 234.13M |
| 73 | QURE | uniQure N.V. | 3.29B | -1.10% | 119,504 | 18.67M |
| 74 | CLDX | Celldex Therapeutics, Inc. | 3.28B | -0.43% | 305,907 | 158.00K |
| 75 | ARQT | Arcutis Biotherapeutics, Inc. | 3.27B | 1.72% | 421,921 | 463.98M |
| 76 | NAMS | NewAmsterdam Pharma Company N.V. | 3.26B | 1.34% | 213,738 | 7.12M |
| 77 | MBX | MBX Biosciences, Inc. | 3.22B | -1.97% | 259,186 | - |
| 78 | IOVA | Iovance Biotherapeutics, Inc. | 3.21B | -0.14% | 4,505,240 | 324.97M |
| 79 | ALMS | Alumis Inc. | 3.18B | -3.65% | 202,906 | 7.40M |
| 80 | TARS | Tarsus Pharmaceuticals, Inc. | 3.09B | -0.15% | 215,186 | 606.33M |
| 81 | IMNM | Immunome, Inc. | 3.08B | -0.88% | 229,561 | 4.02M |
| 82 | IRON | Disc Medicine, Inc. | 3.06B | -0.47% | 133,155 | - |
| 83 | ZLAB | Zai Lab Limited | 2.85B | -1.01% | 687,871 | 449.61M |
| 84 | NRIX | Nurix Therapeutics, Inc. | 2.77B | -1.66% | 213,691 | 36.77M |
| 85 | SLS | SELLAS Life Sciences Group, Inc. | 2.71B | 3.08% | 2,194,198 | - |
| 86 | ATAI | AtaiBeckley Inc. | 2.69B | 0.35% | 3,268,453 | 4.47M |
| 87 | VRDN | Viridian Therapeutics, Inc. | 2.67B | 1.91% | 679,688 | 71.13M |
| 88 | TRVI | Trevi Therapeutics, Inc. | 2.65B | 0.65% | 453,264 | - |
| 89 | BEAM | Beam Therapeutics Inc. | 2.62B | -3.43% | 445,047 | 156.04M |
| 90 | COAG | Hemab Therapeutics Holdings, Inc. | 2.51B | 0.37% | 34,825 | - |
| 91 | PHVS | Pharvaris N.V. | 2.50B | 0.68% | 174,327 | - |
| 92 | RARE | Ultragenyx Pharmaceutical Inc. | 2.48B | -3.48% | 411,705 | 717.00M |
| 93 | KOD | Kodiak Sciences Inc. | 2.48B | -3.59% | 212,301 | - |
| 94 | NKTR | Nektar Therapeutics | 2.45B | -1.24% | 163,102 | 54.59M |
| 95 | URGN | UroGen Pharma Ltd. | 2.38B | -0.90% | 266,797 | 188.73M |
| 96 | OCUL | Ocular Therapeutix, Inc. | 2.35B | 0.66% | 1,243,222 | 52.06M |
| 97 | RAPP | Rapport Therapeutics, Inc. | 2.34B | 0.59% | 77,948 | 20.00M |
| 98 | PGEN | Precigen, Inc. | 2.33B | -0.46% | 1,011,543 | 85.72M |
| 99 | KLRA | Kailera Therapeutics, Inc. | 2.33B | -2.86% | 238,791 | - |
| 100 | NUVB | Nuvation Bio Inc. | 2.31B | 1.47% | 1,520,228 | 169.90M |
| 101 | MLYS | Mineralys Therapeutics, Inc. | 2.31B | 0.23% | 277,060 | - |
| 102 | VCEL | Vericel Corporation | 2.29B | 2.37% | 77,737 | 306.30M |
| 103 | VERA | Vera Therapeutics, Inc. | 2.28B | 0.21% | 302,299 | - |
| 104 | HRMY | Harmony Biosciences Holdings, Inc. | 2.26B | 1.84% | 81,362 | 959.90M |
| 105 | MESO | Mesoblast Limited | 2.22B | -2.17% | 76,598 | 65.38M |
| 106 | PVLA | Palvella Therapeutics, Inc. | 2.19B | -1.00% | 27,770 | - |
| 107 | ADMA | ADMA Biologics, Inc. | 2.13B | 1.82% | 288,883 | 512.28M |
| 108 | NBTX | Nanobiotix S.A. | 2.08B | -3.16% | 98,464 | 38.27M |
| 109 | GENB | Generate Biomedicines, Inc. | 2.08B | 3.23% | 269,708 | 26.48M |
| 110 | AGIO | Agios Pharmaceuticals, Inc. | 2.07B | 3.18% | 246,604 | 98.34M |
| 111 | BHVN | Biohaven Ltd. | 2.06B | -5.60% | 426,686 | - |
| 112 | SEPN | Septerna, Inc. | 2.05B | -0.52% | 97,267 | 98.88M |
| 113 | STOK | Stoke Therapeutics, Inc. | 2.05B | -1.03% | 185,236 | 27.59M |
| 114 | ZBIO | Zenas BioPharma, Inc. | 2.04B | 2.59% | 199,313 | 1.00M |
| 115 | AUPH | Aurinia Pharmaceuticals Inc. | 2.03B | -0.07% | 230,360 | 311.51M |
| 116 | TSHA | Taysha Gene Therapies, Inc. | 2.02B | -0.32% | 390,004 | 5.49M |
| 117 | GHRS | GH Research PLC | 2.01B | -2.17% | 97,606 | - |
| 118 | KARD | Kardigan, Inc. | 1.95B | 1.36% | 95,945 | - |
| 119 | FBRX | Forte Biosciences, Inc. | 1.94B | -0.01% | 322,723 | - |
| 120 | DMRA | Damora Therapeutics, Inc. | 1.92B | -0.23% | 70,651 | - |
| 121 | SRPT | Sarepta Therapeutics, Inc. | 1.90B | -0.99% | 246,740 | 1.97B |
| 122 | IMCR | Immunocore Holdings plc | 1.86B | 3.28% | 165,843 | 430.78M |
| 123 | LKFT | Lakefront Biotherapeutics NV | 1.84B | -0.33% | 115,190 | 1.13B |
| 124 | ZYME | Zymeworks Inc. | 1.83B | 2.09% | 162,705 | 37.13M |
| 125 | XNCR | Xencor, Inc. | 1.78B | 3.68% | 130,330 | 104.97M |
| 126 | SNDX | Syndax Pharmaceuticals, Inc. | 1.77B | 0.25% | 250,869 | 252.25M |
| 127 | ANAB | AnaptysBio, Inc. | 1.75B | -1.21% | 82,149 | 232.39M |
| 128 | AVLN | Avalyn Pharma Inc. | 1.72B | 1.52% | 62,296 | - |
| 129 | BRVE | Braveheart Bio, Inc. | 1.70B | -4.41% | 85,143 | - |
| 130 | FTRE | Fortrea Holdings Inc. | 1.68B | -2.38% | 168,793 | 2.68B |
| 131 | AAPG | Ascentage Pharma Group International | 1.64B | -1.92% | 4,103 | 82.08M |
| 132 | BCAX | Bicara Therapeutics Inc. | 1.64B | -0.76% | 67,017 | - |
| 133 | NTLA | Intellia Therapeutics, Inc. | 1.62B | -4.14% | 1,249,035 | 59.51M |
| 134 | VIR | Vir Biotechnology, Inc. | 1.59B | - | 310,052 | 303.23M |
| 135 | RXRX | Recursion Pharmaceuticals, Inc. | 1.58B | -5.31% | 7,033,428 | 54.86M |
| 136 | TRAX | First Tracks Biotherapeutics, Inc. | 1.58B | 1.20% | 221,242 | - |
| 137 | MAZE | Maze Therapeutics, Inc. | 1.57B | 1.00% | 176,642 | 20.00M |
| 138 | TYRA | Tyra Biosciences, Inc. | 1.55B | -1.05% | 113,378 | - |
| 139 | SLBT | SL Science Holding Limited | 1.54B | -2.17% | 5,540 | 3.27M |
| 140 | INVA | Innoviva, Inc. | 1.54B | 1.43% | 85,382 | 440.00M |
| 141 | LBRX | LB Pharmaceuticals Inc | 1.53B | 2.90% | 207,835 | - |
| 142 | ABSI | Absci Corporation | 1.49B | -6.06% | 1,025,943 | 1.56M |
| 143 | JBIO | Jade Biosciences, Inc. | 1.47B | -1.13% | 135,336 | - |
| 144 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.46B | -1.23% | 477,511 | 208.78M |
| 145 | AVBP | ArriVent BioPharma, Inc. | 1.46B | 1.83% | 92,236 | - |
| 146 | REPL | Replimune Group, Inc. | 1.45B | 5.26% | 581,467 | - |
| 147 | ORIC | ORIC Pharmaceuticals, Inc. | 1.41B | 1.79% | 328,739 | - |
| 148 | MLTX | MoonLake Immunotherapeutics | 1.38B | -0.86% | 325,764 | - |
| 149 | INBX | Inhibrx Biosciences, Inc. | 1.37B | 0.93% | 158,460 | 1.30M |
| 150 | VOR | Vor Biopharma Inc. | 1.37B | 0.39% | 189,533 | - |
| 151 | SVRA | Savara Inc. | 1.36B | -0.37% | 431,052 | - |
| 152 | AKTS | Aktis Oncology, Inc. | 1.36B | -1.44% | 27,121 | 10.06M |
| 153 | CGEM | Cullinan Therapeutics, Inc. | 1.35B | 1.70% | 191,340 | - |
| 154 | ANRO | Alto Neuroscience, Inc. | 1.33B | 0.86% | 187,612 | - |
| 155 | MGTX | MeiraGTx Holdings plc | 1.33B | 0.36% | 120,059 | 397.50M |
| 156 | DRTS | Alpha Tau Medical Ltd. | 1.32B | 0.99% | 200,281 | - |
| 157 | NVAX | Novavax, Inc. | 1.30B | -2.23% | 638,970 | 413.80M |
| 158 | MNKD | MannKind Corporation | 1.29B | 2.95% | 1,175,112 | 393.63M |
| 159 | GLUE | Monte Rosa Therapeutics, Inc. | 1.28B | -2.73% | 239,690 | 28.73M |
| 160 | SPTX | Seaport Therapeutics, Inc. | 1.27B | -2.70% | 17,329 | - |
| 161 | APMD | Apnimed, Inc. | 1.25B | -3.23% | 120,095 | 120.15M |
| 162 | CRVS | Corvus Pharmaceuticals, Inc. | 1.25B | -0.57% | 187,676 | - |
| 163 | IMTX | Immatics N.V. | 1.24B | -1.62% | 144,690 | 43.00M |
| 164 | OMER | Omeros Corporation | 1.24B | -1.27% | 382,921 | 38.42M |
| 165 | LTGO | Latigo Biotherapeutics, Inc. | 1.23B | 0.57% | 59,750 | - |
| 166 | IVA | Inventiva S.A. | 1.11B | -2.77% | 481,341 | 7.94M |
| 167 | KURA | Kura Oncology, Inc. | 1.10B | 9.75% | 2,364,057 | 77.23M |
| 168 | SANA | Sana Biotechnology, Inc. | 1.08B | -2.04% | 511,515 | - |
| 169 | AVTX | Avalo Therapeutics, Inc. | 1.07B | 0.25% | 576,317 | 59.00K |
| 170 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.05B | 0.64% | 448,117 | 41.47M |
| 171 | WVE | Wave Life Sciences Ltd. | 1.03B | 2.75% | 647,133 | 65.37M |
| 172 | JANX | Janux Therapeutics, Inc. | 1.02B | 2.24% | 118,911 | 24.00M |
| 173 | ODTX | Odyssey Therapeutics, Inc. | 995.27M | -0.43% | 81,819 | 99.00K |
| 174 | CLYM | Climb Bio, Inc. | 991.35M | -1.03% | 352,984 | - |
| 175 | GERN | Geron Corporation | 979.77M | -0.33% | 926,204 | 204.56M |
| 176 | ARDX | Ardelyx, Inc. | 979.31M | -3.20% | 1,041,508 | 450.89M |
| 177 | ANNX | Annexon, Inc. | 977.28M | 0.49% | 413,947 | - |
| 178 | ATTO | Attovia Therapeutics, Inc. | 955.24M | -2.25% | 76,397 | 1.35M |
| 179 | SLDB | Solid Biosciences Inc. | 954.30M | -2.20% | 170,307 | - |
| 180 | DSGN | Design Therapeutics, Inc. | 948.74M | 0.40% | 189,909 | - |
| 181 | ABUS | Arbutus Biopharma Corporation | 937.80M | 0.64% | 399,166 | 181.72M |
| 182 | OLMA | Olema Pharmaceuticals, Inc. | 923.54M | -2.00% | 194,233 | - |
| 183 | CADL | Candel Therapeutics, Inc. | 911.34M | -2.06% | 272,263 | - |
| 184 | ACRS | Aclaris Therapeutics, Inc. | 896.44M | 2.87% | 940,817 | 8.22M |
| 185 | DBVT | DBV Technologies S.A. | 880.92M | -0.95% | 110,846 | 5.04M |
| 186 | TBPH | Theravance Biopharma, Inc. | 879.76M | 0.15% | 36,508 | 104.31M |
| 187 | ANL | Adlai Nortye Ltd. | 868.73M | 1.12% | 34,361 | 18.06M |
| 188 | SGP | SpyGlass Pharma, Inc. | 862.29M | - | 14,800 | - |
| 189 | FTH | Faeth Therapeutics, Inc. | 859.45M | 1.50% | 86,361 | - |
| 190 | SLN | Silence Therapeutics plc | 844.14M | -2.30% | 956,236 | 615.00K |
| 191 | PHAR | Pharming Group N.V. | 839.53M | -2.46% | 17,810 | 366.48M |
| 192 | IMMX | Immix Biopharma, Inc. | 825.56M | 1.76% | 333,117 | - |
| 193 | OBX | Obsidian Therapeutics, Inc. | 810.20M | 6.64% | 22,912 | - |
| 194 | RIGL | Rigel Pharmaceuticals, Inc. | 804.54M | 1.46% | 52,183 | 276.79M |
| 195 | OCS | Oculis Holding AG | 800.66M | -1.29% | 78,903 | 1.45M |
| 196 | FDMT | 4D Molecular Therapeutics, Inc. | 793.86M | -1.20% | 560,435 | 92.01M |
| 197 | AURA | Aura Biosciences, Inc. | 786.70M | -1.22% | 189,199 | - |
| 198 | MNPR | Monopar Therapeutics Inc. | 774.92M | -0.89% | 62,059 | - |
| 199 | DRUG | Bright Minds Biosciences Inc. | 769.03M | 1.94% | 38,043 | - |
| 200 | ACHV | Achieve Life Sciences, Inc. | 757.36M | -1.87% | 299,998 | - |
| 201 | PHAT | Phathom Pharmaceuticals, Inc. | 748.23M | 1.51% | 355,134 | 239.66M |
| 202 | CTMX | CytomX Therapeutics, Inc. | 729.96M | -2.90% | 759,141 | 18.30M |
| 203 | GYRE | Gyre Therapeutics, Inc. | 724.21M | 0.29% | 8,288 | 109.82M |
| 204 | RGNX | REGENXBIO Inc. | 721.52M | -3.53% | 141,292 | 174.48M |
| 205 | NGNE | Neurogene Inc. | 719.01M | -2.04% | 16,549 | 925.00K |
| 206 | STTK | Shattuck Labs, Inc. | 718.60M | -3.11% | 131,418 | 1.00M |
| 207 | CBIO | Crescent Biopharma, Inc. | 715.21M | -4.41% | 60,792 | 11.88M |
| 208 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 711.95M | -1.77% | 88,336 | - |
| 209 | ALLO | Allogene Therapeutics, Inc. | 704.77M | -1.93% | 1,470,655 | 4.64M |
| 210 | TECX | Tectonic Therapeutic, Inc. | 701.43M | 6.00% | 181,101 | - |
| 211 | HELP | Cybin Inc. | 699.18M | -2.51% | 248,785 | - |
| 212 | ZVRA | Zevra Therapeutics, Inc. | 682.32M | -0.35% | 341,239 | 136.07M |
| 213 | AGMB | AgomAb Therapeutics NV | 676.17M | 0.37% | 12,504 | - |
| 214 | VSTM | Verastem, Inc. | 675.60M | 3.90% | 855,502 | 87.53M |
| 215 | VALN | Valneva SE | 674.85M | -3.26% | 44,017 | 163.30M |
| 216 | NVCT | Nuvectis Pharma, Inc. | 658.15M | 5.87% | 46,306 | - |
| 217 | SGMT | Sagimet Biosciences Inc. | 653.91M | 0.86% | 403,902 | - |
| 218 | SPRY | ARS Pharmaceuticals, Inc. | 644.92M | 3.93% | 625,809 | 116.93M |
| 219 | CRMD | CorMedix Inc. | 634.08M | 6.06% | 555,686 | 462.25M |
| 220 | ASMB | Assembly Biosciences, Inc. | 633.32M | 3.65% | 131,683 | 74.85M |
| 221 | MDXG | MiMedx Group, Inc. | 631.14M | 3.34% | 203,922 | 355.17M |
| 222 | AUTL | Autolus Therapeutics plc | 621.49M | 2.41% | 1,229,225 | 117.39M |
| 223 | ARVN | Arvinas, Inc. | 600.25M | -0.22% | 113,737 | 316.70M |
| 224 | EIKN | Eikon Therapeutics, Inc. | 585.52M | 3.25% | 163,464 | - |
| 225 | PRLD | Prelude Therapeutics Incorporated | 580.89M | 0.18% | 77,564 | 22.42M |
| 226 | ALT | Altimmune, Inc. | 580.64M | -0.50% | 777,804 | 31.00K |
| 227 | ARTV | Artiva Biotherapeutics, Inc. | 571.04M | -0.51% | 84,930 | 251.00K |
| 228 | OABI | OmniAb, Inc. | 565.57M | 1.83% | 2,222,995 | 38.46M |
| 229 | ZURA | Zura Bio Limited | 565.39M | 3.87% | 410,258 | - |
| 230 | OVID | Ovid Therapeutics Inc. | 552.69M | -2.08% | 881,637 | 1.58M |
| 231 | PRME | Prime Medicine, Inc. | 546.17M | -3.15% | 472,410 | 4.07M |
| 232 | CTNM | Contineum Therapeutics, Inc. | 543.63M | -0.55% | 71,637 | - |
| 233 | MPLT | MapLight Therapeutics, Inc. | 534.97M | 2.58% | 145,268 | - |
| 234 | KYTX | Kyverna Therapeutics, Inc. | 525.05M | -5.14% | 322,009 | - |
| 235 | EVMN | Evommune, Inc. | 515.71M | -0.28% | 120,341 | 10.00M |
| 236 | CCCC | C4 Therapeutics, Inc. | 512.40M | -2.34% | 1,424,362 | 35.04M |
| 237 | RLMD | Relmada Therapeutics, Inc. | 509.35M | 0.10% | 234,572 | - |
| 238 | ENTX | Entera Bio Ltd. | 498.65M | -0.69% | 87,585 | 42.00K |
| 239 | BLSM | BlossomHill Therapeutics, Inc. | 493.39M | -1.70% | 89,958 | - |
| 240 | SCTX | Scribe Therapeutics Inc. | 492.36M | 23.17% | 206,023 | 36.28M |
| 241 | RZLT | Rezolute, Inc. | 485.77M | -0.64% | 166,681 | - |
| 242 | CABA | Cabaletta Bio, Inc. | 485.75M | -0.87% | 2,933,511 | - |
| 243 | PBYI | Puma Biotechnology, Inc. | 467.16M | 2.61% | 35,401 | 231.24M |
| 244 | EYPT | EyePoint, Inc. | 456.92M | 8.83% | 9,241,655 | 2.79M |
| 245 | QTTB | Q32 Bio Inc. | 453.98M | -4.39% | 105,670 | 53.74M |
| 246 | OCGN | Ocugen, Inc. | 452.71M | -2.91% | 942,224 | 4.58M |
| 247 | EPRX | Eupraxia Pharmaceuticals Inc. | 451.39M | -0.59% | 120,865 | - |
| 248 | DNA | Ginkgo Bioworks Holdings, Inc. | 447.81M | -3.90% | 381,183 | 132.42M |
| 249 | PRTA | Prothena Corporation plc | 442.52M | -2.93% | 59,236 | 54.53M |
| 250 | BNTC | Benitec Biopharma Inc. | 438.02M | -2.45% | 139,138 | - |
| 251 | LRMR | Larimar Therapeutics, Inc. | 433.71M | -3.82% | 216,073 | - |
| 252 | EDIT | Editas Medicine, Inc. | 433.10M | -0.70% | 893,869 | 47.01M |
| 253 | IKT | Inhibikase Therapeutics, Inc. | 424.23M | -2.51% | 102,025 | 1.00 |
| 254 | XFOR | X4 Pharmaceuticals, Inc. | 416.91M | -2.21% | 94,585 | 15.85M |
| 255 | FENC | Fennec Pharmaceuticals Inc. | 414.49M | -0.08% | 28,733 | 59.22M |
| 256 | AVIR | Atea Pharmaceuticals, Inc. | 413.86M | -1.15% | 38,438 | - |
| 257 | PROK | ProKidney Corp. | 412.67M | -2.50% | 248,224 | 818.00K |
| 258 | CMPX | Compass Therapeutics, Inc. | 411.50M | -1.08% | 565,730 | 850.00K |
| 259 | LXEO | Lexeo Therapeutics, Inc. | 401.60M | -1.71% | 125,314 | - |
| 260 | FHTX | Foghorn Therapeutics Inc. | 398.56M | -0.42% | 42,637 | 36.74M |
| 261 | CAPR | Capricor Therapeutics, Inc. | 395.05M | -8.79% | 4,840,396 | 11.13M |
| 262 | VTVT | vTv Therapeutics Inc. | 385.54M | -0.89% | 9,110 | 36.84M |
| 263 | ENTA | Enanta Pharmaceuticals, Inc. | 378.63M | 1.33% | 37,300 | 65.26M |
| 264 | UPB | Upstream Bio, Inc. | 376.82M | -3.64% | 113,972 | 3.16M |
| 265 | CUVL | Clinuvel Pharmaceuticals Limited | 371.49M | -1.82% | 5,865 | 64.24M |
| 266 | RCKT | Rocket Pharmaceuticals, Inc. | 362.26M | -2.94% | 403,355 | - |
| 267 | PALI | Palisade Bio, Inc. | 361.61M | -3.49% | 293,493 | 500.00K |
| 268 | STRO | Sutro Biopharma, Inc. | 351.69M | -4.80% | 124,223 | 45.70M |
| 269 | DMAC | DiaMedica Therapeutics Inc. | 351.60M | -1.51% | 17,348 | - |
| 270 | IPSC | Century Therapeutics, Inc. | 347.66M | -1.54% | 140,403 | 109.16M |
| 271 | SABS | SAB Biotherapeutics, Inc. | 344.84M | 0.53% | 112,253 | 114.70K |
| 272 | ABEO | Abeona Therapeutics Inc. | 340.82M | 0.34% | 245,038 | 25.52M |
| 273 | LYEL | Lyell Immunopharma, Inc. | 340.38M | 2.51% | 33,169 | 27.00K |
| 274 | VCRE | Vicore Pharma Holding AB (publ) | 339.81M | - | 137 | 370.61K |
| 275 | GALT | Galectin Therapeutics Inc. | 338.85M | -4.27% | 84,625 | - |
| 276 | AGEN | Agenus Inc. | 335.85M | 4.34% | 296,711 | 132.69M |
| 277 | IMRX | Immuneering Corporation | 322.84M | -4.41% | 225,061 | - |
| 278 | VNDA | Vanda Pharmaceuticals Inc. | 319.24M | 0.38% | 329,321 | 215.72M |
| 279 | OBIO | Orchestra BioMed Holdings, Inc. | 313.15M | 10.38% | 258,665 | 31.98M |
| 280 | CAMP | Camp4 Therapeutics Corporation | 309.06M | -1.50% | 37,295 | 4.22M |
| 281 | IFRX | InflaRx N.V. | 305.79M | 0.24% | 245,778 | -11.54K |
| 282 | IRD | Opus Genetics, Inc. | 300.75M | -0.96% | 247,099 | 9.86M |
| 283 | FATE | Fate Therapeutics, Inc. | 296.64M | -2.86% | 449,842 | 6.49M |
| 284 | NMRA | Neumora Therapeutics, Inc. | 295.94M | 3.62% | 198,720 | - |
| 285 | TTRX | Turn Therapeutics Inc. | 295.50M | 0.10% | 4,743 | - |
| 286 | ELDN | Eledon Pharmaceuticals, Inc. | 294.05M | 0.98% | 175,642 | - |
| 287 | FULC | Fulcrum Therapeutics, Inc. | 290.69M | -0.78% | 1,292,426 | 80.00M |
| 288 | AVXL | Anavex Life Sciences Corp. | 288.21M | -3.12% | 105,471 | - |
| 289 | ALXO | ALX Oncology Holdings Inc. | 284.85M | 4.57% | 306,577 | - |
| 290 | SRZN | Surrozen, Inc. | 281.50M | 0.71% | 41,090 | 11.51M |
| 291 | RNAC | Cartesian Therapeutics, Inc. | 279.11M | 0.49% | 51,482 | 1.48M |
| 292 | PRQR | ProQR Therapeutics N.V. | 278.01M | 2.07% | 322,362 | 21.05M |
| 293 | BCYC | Bicycle Therapeutics plc | 277.17M | -1.00% | 21,959 | 61.21M |
| 294 | WHWK | Whitehawk Therapeutics, Inc. | 269.08M | 1.72% | 41,980 | 7.15M |
| 295 | LCTX | Lineage Cell Therapeutics, Inc. | 268.08M | - | 593,739 | 13.08M |
| 296 | ZNTL | Zentalis Pharmaceuticals, Inc. | 264.83M | -0.27% | 272,761 | 26.87M |
| 297 | SLGL | Sol-Gel Technologies Ltd. | 264.79M | -2.42% | 15,866 | 18.47M |
| 298 | TRDA | Entrada Therapeutics, Inc. | 261.77M | -0.82% | 20,930 | 4.69M |
| 299 | MGNX | MacroGenics, Inc. | 261.49M | 1.11% | 143,213 | 175.14M |
| 300 | CNXU | Conexeu Sciences Inc. | 261.43M | -0.10% | 133,012 | - |
| 301 | ADAG | Adagene Inc. | 261.19M | 1.57% | 48,779 | 9.29M |
| 302 | SION | Sionna Therapeutics, Inc. | 258.61M | -3.21% | 827,342 | - |
| 303 | ALEC | Alector, Inc. | 254.58M | 11.22% | 2,746,884 | 13.86M |
| 304 | PYXS | Pyxis Oncology, Inc. | 254.39M | 0.99% | 112,984 | 11.04M |
| 305 | ACIU | AC Immune SA | 253.04M | 0.59% | 35,708 | 21.67M |
| 306 | GLSI | Greenwich LifeSciences, Inc. | 251.88M | -1.27% | 33,876 | - |
| 307 | VOGX | Vogenx, Inc. | 251.18M | 14.59% | 574,370 | - |
| 308 | YDES | YD Bio Limited | 251.04M | 5.93% | 29,626 | 510.36K |
| 309 | IVVD | Invivyd, Inc. | 246.86M | 13.10% | 3,470,265 | 58.37M |
| 310 | NAGE | Niagen Bioscience, Inc. | 241.84M | 0.33% | 108,226 | 129.08M |
| 311 | ARCT | Arcturus Therapeutics Holdings Inc. | 235.06M | 1.60% | 226,021 | 29.37M |
| 312 | TARA | Protara Therapeutics, Inc. | 233.13M | -0.88% | 140,421 | - |
| 313 | CLLS | Cellectis S.A. | 229.89M | -3.22% | 21,448 | 63.82M |
| 314 | IMUX | Immunic, Inc. | 224.04M | 2.43% | 50,665 | - |
| 315 | CGEN | Compugen Ltd. | 220.71M | -0.85% | 48,532 | 74.00M |
| 316 | RNA | Atrium Therapeutics, Inc. | 219.89M | -0.81% | 35,785 | 35.84M |
| 317 | TNXP | Tonix Pharmaceuticals Holding Corp. | 218.16M | 0.47% | 78,837 | 29.10M |
| 318 | ANTX | AN2 Therapeutics, Inc. | 216.98M | 0.35% | 76,521 | - |
| 319 | NBP | NovaBridge Biosciences | 216.26M | -3.11% | 88,287 | - |
| 320 | DTIL | Precision BioSciences, Inc. | 211.70M | 3.65% | 76,031 | 45.06M |
| 321 | NERV | Minerva Neurosciences, Inc. | 210.57M | -0.23% | 6,864 | - |
| 322 | MSLE | Satellos Bioscience Inc. | 204.25M | -1.48% | 1,199 | - |
| 323 | CHRS | Coherus Oncology, Inc. | 203.94M | 14.78% | 1,474,865 | 50.94M |
| 324 | KROS | Keros Therapeutics, Inc. | 202.63M | -2.48% | 70,863 | 15.01M |
| 325 | PEPG | PepGen Inc. | 202.24M | -3.95% | 244,655 | - |
| 326 | VYGR | Voyager Therapeutics, Inc. | 200.26M | 0.62% | 122,165 | 34.46M |
| 327 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 197.28M | -2.76% | 146,324 | - |
| 328 | IPHA | Innate Pharma S.A. | 196.48M | -7.08% | 24,107 | 10.57M |
| 329 | ABOS | Acumen Pharmaceuticals, Inc. | 192.36M | - | 70,284 | - |
| 330 | ORMP | Oramed Pharmaceuticals Inc. | 191.76M | 0.88% | 86,337 | 2.00M |
| 331 | ACOG | Alpha Cognition Inc. | 188.56M | -2.04% | 53,807 | 15.26M |
| 332 | KRRO | Korro Bio, Inc. | 188.27M | -2.70% | 20,461 | 2.38M |
| 333 | PLX | Protalix BioTherapeutics, Inc. | 184.11M | -0.22% | 58,530 | 80.62M |
| 334 | NGEN | NervGen Pharma Corp. | 176.11M | -1.49% | 174,628 | - |
| 335 | MDWD | MediWound Ltd. | 175.58M | 1.57% | 22,043 | 11.86M |
| 336 | ARMP | Armata Pharmaceuticals, Inc. | 169.18M | 1.56% | 10,048 | 5.54M |
| 337 | NKTX | Nkarta, Inc. | 167.60M | -3.70% | 72,894 | - |
| 338 | OKUR | OnKure Therapeutics, Inc. | 166.24M | -0.12% | 15,361 | - |
| 339 | CRBU | Caribou Biosciences, Inc. | 165.64M | -1.59% | 239,182 | 10.04M |
| 340 | CDXS | Codexis, Inc. | 164.81M | -5.35% | 405,983 | 77.68M |
| 341 | CNTB | Connect Biopharma Holdings Limited | 159.33M | 1.61% | 101,978 | 2.95M |
| 342 | CNTN | Canton Strategic Holdings, Inc. | 158.17M | -1.98% | 79,598 | 1.50M |
| 343 | MOLN | Molecular Partners AG | 157.47M | 0.94% | 531 | 856.30K |
| 344 | UNCY | Unicycive Therapeutics, Inc. | 157.10M | 1.26% | 439,366 | - |
| 345 | HUMA | Humacyte, Inc. | 155.09M | -0.41% | 3,104,037 | 2.12M |
| 346 | TNYA | Tenaya Therapeutics, Inc. | 155.01M | -1.26% | 1,543,319 | 1.34M |
| 347 | EQ | Equillium, Inc. | 154.27M | -1.61% | 318,388 | 4.39M |
| 348 | KZIA | Kazia Therapeutics Limited | 152.73M | -1.43% | 53,072 | 1.27M |
| 349 | SPRB | Spruce Biosciences, Inc. | 152.41M | 0.21% | 28,789 | 697.00K |
| 350 | MIST | Milestone Pharmaceuticals Inc. | 150.92M | -2.64% | 481,743 | 2.34M |
| 351 | LENZ | LENZ Therapeutics, Inc. | 149.56M | -0.63% | 173,820 | 21.48M |
| 352 | MENS | Jyong Biotech Ltd. | 148.84M | -0.25% | 23,049 | - |
| 353 | HURA | TuHURA Biosciences, Inc. | 142.65M | -1.75% | 106,399 | - |
| 354 | TLSA | Tiziana Life Sciences Ltd | 140.95M | -5.22% | 415,438 | - |
| 355 | NRXP | NRx Pharmaceuticals, Inc. | 140.40M | -2.33% | 198,477 | 3.39M |
| 356 | AARD | Aardvark Therapeutics, Inc. | 139.52M | -5.42% | 27,653 | - |
| 357 | PMN | ProMIS Neurosciences, Inc. | 130.48M | -0.75% | 8,403 | - |
| 358 | NTHI | NeOnc Technologies Holdings, Inc. | 128.76M | 5.50% | 190,348 | 39.99K |
| 359 | CBUS | Cibus, Inc. | 126.71M | -0.60% | 42,828 | 4.35M |
| 360 | OTLK | Outlook Therapeutics, Inc. | 120.18M | -4.39% | 26,178,535 | -1.16M |
| 361 | GNLX | Genelux Corporation | 119.90M | - | 84,646 | 8.00K |
| 362 | INO | Inovio Pharmaceuticals, Inc. | 117.87M | -0.87% | 1,927,062 | 65.34K |
| 363 | YARW | Yarrow Bioscience, Inc. | 116.93M | 0.87% | 4,028 | - |
| 364 | BDTX | Black Diamond Therapeutics, Inc. | 116.36M | -1.20% | 122,684 | 70.00M |
| 365 | RANI | Rani Therapeutics Holdings, Inc. | 115.89M | 6.78% | 1,003,716 | 4.88M |
| 366 | VANI | Vivani Medical, Inc. | 115.12M | -1.11% | 34,806 | - |
| 367 | GUTS | Fractyl Health, Inc. | 114.61M | 9.09% | 724,167 | 3.00K |
| 368 | ENGN | enGene Therapeutics Inc. | 113.88M | - | 159,512 | - |
| 369 | ANIX | Anixa Biosciences, Inc. | 113.30M | -4.58% | 73,000 | - |
| 370 | SEER | Seer, Inc. | 111.85M | -0.49% | 56,056 | 14.22M |
| 371 | COYA | Coya Therapeutics, Inc. | 110.72M | 1.07% | 15,094 | 8.02M |
| 372 | ONCY | Oncolytics Biotech Inc. | 108.36M | 3.29% | 297,510 | - |
| 373 | NAUT | Nautilus Biotechnology, Inc. | 108.10M | -3.52% | 181,300 | 190.00K |
| 374 | INDP | Indaptus Therapeutics, Inc. | 105.22M | -7.08% | 192,891 | - |
| 375 | CUE | Cue Biopharma, Inc. | 105.01M | -9.55% | 142,037 | 37.66M |
| 376 | PLYX | Polaryx Therapeutics, Inc. | 103.93M | -0.71% | 59,040 | - |
| 377 | BMEA | Biomea Fusion, Inc. | 97.49M | -0.37% | 498,230 | - |
| 378 | ACET | Adicet Bio, Inc. | 95.59M | 1.60% | 42,815 | - |
| 379 | PTHS | Pelthos Therapeutics Inc. | 95.44M | 6.02% | 13,168 | 43.30M |
| 380 | KLRS | Kalaris Therapeutics, Inc. | 95.10M | 0.88% | 9,717 | - |
| 381 | CGTX | Cognition Therapeutics, Inc. | 94.79M | -2.27% | 215,636 | - |
| 382 | PYPD | PolyPid Ltd. | 94.25M | -2.72% | 18,436 | - |
| 383 | TENX | Tenax Therapeutics, Inc. | 94.23M | -3.80% | 4,614,100 | - |
| 384 | FBIO | Fortress Biotech, Inc. | 93.72M | -0.35% | 216,089 | 68.47M |
| 385 | ALDX | Aldeyra Therapeutics, Inc. | 92.30M | -1.92% | 356,461 | - |
| 386 | RLYB | Rallybio Corporation | 89.96M | -0.35% | 5,387 | 646.00K |
| 387 | ICCC | ImmuCell Corporation | 88.66M | 1.03% | 2,498 | 30.68M |
| 388 | GANX | Gain Therapeutics, Inc. | 85.98M | -3.43% | 159,193 | - |
| 389 | ATRA | Atara Biotherapeutics, Inc. | 84.97M | 1.26% | 2,634 | 6.19M |
| 390 | ACRV | Acrivon Therapeutics, Inc. | 84.85M | -3.41% | 180,296 | - |
| 391 | MAIA | MAIA Biotechnology, Inc. | 83.33M | -1.44% | 75,256 | - |
| 392 | VRCA | Verrica Pharmaceuticals Inc. | 82.97M | -1.23% | 14,948 | 30.32M |
| 393 | ATHE | Alterity Therapeutics Limited | 81.97M | -0.22% | 2,672 | 4.43M |
| 394 | ELTX | Elicio Therapeutics, Inc. | 80.42M | 1.32% | 118,272 | - |
| 395 | OKYO | OKYO Pharma Limited | 80.29M | 0.66% | 40,980 | - |
| 396 | NRXS | NeurAxis, Inc. | 79.24M | 0.48% | 15,175 | 5.32M |
| 397 | RNTX | Rein Therapeutics Inc. | 74.49M | 3.51% | 128,184 | - |
| 398 | ANVS | Annovis Bio, Inc. | 74.44M | 0.57% | 203,299 | - |
| 399 | LONA | LeonaBio, Inc. | 73.91M | 2.06% | 5,046 | - |
| 400 | TELO | Telomir Pharmaceuticals, Inc. | 73.59M | 0.94% | 12,038 | - |
| 401 | DWTX | Dogwood Therapeutics, Inc. | 72.30M | 4.37% | 9,763 | - |
| 402 | CSBR | Champions Oncology, Inc. | 72.25M | 3.38% | 9,062 | 59.43M |
| 403 | IBIO | iBio, Inc. | 71.54M | -0.69% | 427,688 | 300.00K |
| 404 | CRDF | Cardiff Oncology, Inc. | 70.55M | 0.29% | 105,351 | 508.00K |
| 405 | GOSS | Gossamer Bio, Inc. | 70.30M | 2.71% | 2,567,482 | 53.29M |
| 406 | PLRX | Pliant Therapeutics, Inc. | 69.66M | 2.27% | 1,014,636 | - |
| 407 | ELOX | Eloxx Pharmaceuticals, Inc. | 69.59M | -6.66% | 21,989 | - |
| 408 | CING | Cingulate Inc. | 69.37M | -1.15% | 40,031 | - |
| 409 | SPRO | Spero Therapeutics, Inc. | 69.23M | -0.10% | 183,822 | 47.00M |
| 410 | XBIT | XBiotech Inc. | 68.60M | -2.60% | 37,799 | - |
| 411 | PMVP | PMV Pharmaceuticals, Inc. | 66.20M | -0.70% | 57,241 | - |
| 412 | MNOV | MediciNova, Inc. | 65.96M | 1.52% | 30,486 | 920.48K |
| 413 | BOLD | Boundless Bio, Inc. | 64.83M | 0.71% | 73,979 | - |
| 414 | IMA | ImageneBio, Inc. | 64.53M | 1.88% | 1,479 | 800.00K |
| 415 | OSTX | OS Therapies Incorporated | 64.36M | -1.70% | 96,810 | - |
| 416 | XLO | Xilio Therapeutics, Inc. | 63.17M | 1.16% | 2,639 | 64.09M |
| 417 | HYFT | MindWalk Holdings Corp. | 60.14M | -3.76% | 99,386 | 11.43M |
| 418 | EXOZ | eXoZymes, Inc. | 59.04M | 7.46% | 281 | -700.00 |
| 419 | INMB | INmune Bio Inc. | 58.98M | -0.23% | 110,218 | 50.00K |
| 420 | HRTX | Heron Therapeutics, Inc. | 57.62M | -5.16% | 1,431,017 | 151.18M |
| 421 | INKT | MiNK Therapeutics, Inc. | 57.29M | 2.50% | 1,468 | - |
| 422 | EDSA | Edesa Biotech, Inc. | 55.58M | 2.12% | 35,988 | - |
| 423 | BSEM | BioStem Technologies, Inc. | 55.33M | 3.33% | 15,683 | 34.59M |
| 424 | IMMP | Immutep Limited | 54.49M | 2.23% | 35,182 | 5.28M |
| 425 | TCRX | TScan Therapeutics, Inc. | 54.22M | 2.11% | 92,456 | 7.11M |
| 426 | RNXT | RenovoRx, Inc. | 53.25M | -1.67% | 272,700 | 1.98M |
| 427 | APLM | Apollomics, Inc. | 52.71M | 1.91% | 15,994 | 8.84M |
| 428 | ATYR | aTyr Pharma, Inc. | 50.82M | -0.15% | 226,503 | 190.00K |
| 429 | TIL | Instil Bio, Inc. | 50.73M | 1.63% | 1,827 | - |
| 430 | IBO | Impact BioMedical Inc. | 50.56M | -1.78% | 20,811 | 35.00K |
| 431 | MREO | Mereo BioPharma Group plc | 47.41M | -3.51% | 388,227 | 500.00K |
| 432 | ALPS | Alps Group Inc | 46.60M | -12.54% | 90,133 | 3.74M |
| 433 | MGX | Metagenomi Therapeutics, Inc. | 46.09M | - | 14,804 | 13.56M |
| 434 | VRXA | Veraxa Biotech AG | 45.96M | -2.01% | 39,140 | - |
| 435 | CNTX | Context Therapeutics Inc. | 45.94M | -5.71% | 1,650,609 | - |
| 436 | GRCE | Grace Therapeutics, Inc. | 44.60M | -1.85% | 46,109 | - |
| 437 | HYPD | Hyperion DeFi, Inc. | 44.13M | - | 34,650 | 1.40M |
| 438 | MCRB | Seres Therapeutics, Inc. | 44.04M | -1.77% | 28,420 | 1.88M |
| 439 | VERU | Veru Inc. | 43.99M | -1.90% | 44,094 | 16.89M |
| 440 | KPTI | Karyopharm Therapeutics Inc. | 42.87M | 4.42% | 262,738 | 146.62M |
| 441 | SER | Serina Therapeutics, Inc. | 41.69M | -2.46% | 10,843 | 130.00K |
| 442 | FLNA | Filana Therapeutics, Inc. | 41.54M | -3.37% | 172,317 | - |
| 443 | ALGS | Aligos Therapeutics, Inc. | 41.40M | 0.84% | 16,199 | 31.52M |
| 444 | NTRB | Nutriband Inc. | 40.24M | 2.48% | 1,508 | 1.80M |
| 445 | CRVO | CervoMed Inc. | 38.55M | -2.30% | 207,476 | 331.30K |
| 446 | RADX | Radiopharm Theranostics Limited | 37.01M | 3.00% | 14,321 | 10.86M |
| 447 | ESLA | Estrella Immunopharma, Inc. | 33.78M | 3.25% | 7,164 | - |
| 448 | ATNM | Actinium Pharmaceuticals, Inc. | 33.33M | 0.95% | 43,975 | 35.09M |
| 449 | LTRN | Lantern Pharma Inc. | 32.66M | -1.73% | 32,573 | - |
| 450 | QNCX | Quince Therapeutics, Inc. | 31.81M | -4.68% | 5,789 | - |
| 451 | NXTC | NextCure, Inc. | 31.31M | -11.28% | 109,266 | - |
| 452 | LITS | Lite Strategy, Inc. | 30.75M | 2.70% | 53,207 | - |
| 453 | NNVC | NanoViricides, Inc. | 30.10M | -2.84% | 151,455 | - |
| 454 | BYSI | BeyondSpring Inc. | 29.98M | 2.46% | 76,947 | 1.88M |
| 455 | BCTX | BriaCell Therapeutics Corp. | 29.48M | -0.29% | 29,376 | - |
| 456 | GRDX | GridAI Technologies Corp. | 29.46M | 5.32% | 102,193 | - |
| 457 | IGC | IGC Pharma, Inc. | 28.70M | -0.84% | 241,189 | 1.11M |
| 458 | KYNB | Kyntra Bio, Inc. | 28.41M | 3.06% | 8,198 | 4.62M |
| 459 | GNTA | Genenta Science S.p.A. | 28.07M | -5.56% | 21,061 | - |
| 460 | DYAI | Dyadic International, Inc. | 28.05M | -1.35% | 83,217 | 3.80M |
| 461 | TVGN | Tevogen Inc. | 27.76M | - | 167 | - |
| 462 | CVM | CEL-SCI Corporation | 27.45M | 1.33% | 35,374 | - |
| 463 | ENLV | Enlivex Ltd. | 26.05M | -5.70% | 72,115 | - |
| 464 | OSRH | OSR Health, Inc. | 25.83M | 24.73% | 79,315,012 | 1.81M |
| 465 | BRNS | Barinthus Biotherapeutics plc | 25.73M | 6.15% | 20,668 | 14.97M |
| 466 | EVAX | Evaxion A/S | 25.69M | -1.60% | 5,295 | 7.53M |
| 467 | ATOS | Atossa Therapeutics, Inc. | 25.65M | -7.89% | 40,691 | - |
| 468 | LGVN | Longeveron Inc. | 25.36M | -3.00% | 256,172 | 1.19M |
| 469 | ACTU | Actuate Therapeutics, Inc. | 25.12M | 6.06% | 115,461 | - |
| 470 | JSPR | Jasper Therapeutics, Inc. | 24.90M | -10.95% | 645,441 | - |
| 471 | QNTM | Quantum BioPharma Ltd. | 23.99M | -9.78% | 176,586 | - |
| 472 | CALC | CalciMedica, Inc. | 22.07M | -2.43% | 46,578 | - |
| 473 | CELU | Celularity Inc. | 21.68M | 7.61% | 3,252 | 26.55M |
| 474 | CNSY | Cerenome, Inc. | 21.63M | -1.78% | 41,616 | 4.20M |
| 475 | NEUP | Neuphoria Therapeutics Inc. | 21.62M | 3.88% | 217,898 | -13.27K |
| 476 | COCP | Cocrystal Pharma, Inc. | 21.19M | 0.92% | 53,771 | 330.00K |
| 477 | ALLR | Allarity Therapeutics, Inc. | 21.00M | -1.49% | 16,205 | 345.00K |
| 478 | ABVC | ABVC BioPharma, Inc. | 20.97M | -2.34% | 33,438 | 797.92K |
| 479 | CLRB | Cellectar Biosciences, Inc. | 20.70M | 1.17% | 23,543 | - |
| 480 | HOWL | Werewolf Therapeutics, Inc. | 19.82M | 0.57% | 56,415 | 21.00M |
| 481 | PLRZ | Polyrizon Ltd. | 19.73M | -4.01% | 210,684 | - |
| 482 | CYCN | Cyclerion Therapeutics, Inc. | 19.58M | 5.46% | 6,280 | 1.90M |
| 483 | MRKR | Marker Therapeutics, Inc. | 19.34M | - | 20,919 | 2.69M |
| 484 | LEXX | Lexaria Bioscience Corp. | 18.24M | 6.98% | 17,368 | 194.00K |
| 485 | PTN | Palatin Technologies, Inc. | 17.74M | 7.74% | 7,031 | 12.88M |
| 486 | LPCN | Lipocine Inc. | 17.64M | 4.39% | 11,977 | 1.57M |
| 487 | NCEL | NewcelX Ltd. | 17.55M | - | 3,118 | - |
| 488 | PLUR | Pluri Inc. | 17.26M | - | 9,106 | 1.08M |
| 489 | TVRD | Tvardi Therapeutics, Inc. | 17.11M | -1.94% | 21,933 | - |
| 490 | KTTA | Pasithea Therapeutics Corp. | 16.95M | 6.15% | 47,929 | - |
| 491 | KALA | KALA BIO, Inc. | 16.78M | -0.86% | 11,448 | - |
| 492 | TPST | Tempest Therapeutics, Inc. | 16.70M | -7.52% | 132,520 | - |
| 493 | MLEC | Moolec Science SA | 16.23M | -8.98% | 13,741 | 7.83M |
| 494 | CTXR | Citius Pharmaceuticals, Inc. | 15.57M | 0.93% | 190,769 | 7.11M |
| 495 | HIND | Vyome Holdings, Inc. | 15.44M | -3.08% | 1,882 | 129.73K |
| 496 | AKTX | Akari Therapeutics, Plc | 14.99M | 2.39% | 52,232 | - |
| 497 | NRSN | NeuroSense Therapeutics Ltd. | 14.98M | -6.23% | 91,912 | - |
| 498 | PASG | Passage Bio, Inc. | 14.80M | 1.32% | 3,736 | - |
| 499 | ICU | SeaStar Medical Holding Corporation | 14.50M | 1.23% | 14,735 | 1.71M |
| 500 | INTS | Intensity Therapeutics, Inc. | 13.68M | 0.96% | 1,306 | - |